Loading company…
Tabomedex Biosciences researches drug candidates for type 2 diabetes.
Tabomedex Biosciences is a Massachusetts-based biotechnology company researching treatments for type 2 diabetes. Its work examines MK2 inhibition as a way to control blood glucose levels. Team members include Dr. Ira Tabas and Lale Ozcan, whose research focuses on metabolic signaling and homeostasis.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in